Erythema Multiforme Major following SARS‐CoV‐2 vaccine | Zendy

Saibene Alberto Maria | Zendy; Alliata Andrea | Zendy; Cozzi Anna Teresa | Zendy; Ottavi Alice | Zendy; Spagnolini Sofia | Zendy; Pipolo Carlotta | Zendy; Maccari Alberto | Zendy; Felisati Giovanni | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Erythema Multiforme Major following SARS‐CoV‐2 vaccine

Author(s) -

Saibene Alberto Maria,

Alliata Andrea,

Cozzi Anna Teresa,

Ottavi Alice,

Spagnolini Sofia,

Pipolo Carlotta,

Maccari Alberto,

Felisati Giovanni

Publication year - 2021

Publication title -

clinical case reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.21

H-Index - 9

ISSN - 2050-0904

DOI - 10.1002/ccr3.4947

Subject(s) - erythema multiforme , medicine , erythema , dermatology , covid-19 , intensive care medicine , pathology , disease , infectious disease (medical specialty)

Erythema multiforme major, an immune‐mediated skin reaction to infections or medications with oral involvement, should be taken into account as a potential side effect of several vaccines, including SARS‐CoV‐2. Correct patient history collection allows prompt recognition and subsequent successful medical management with oral corticosteroids.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research